- PRGF - ENDORET®
- Medical specialties
- BTI APNIA®
- Diagnosis
- Treatment

PRGF - ENDORET® technology is an autologous regenerative medicine tool for use in dentistry and oral surgery.From a small sample of the patient’s own blood, a plasma fraction enriched in growth factors is obtained, which may be used as an adjunct to dental treatments to support the physiological processes of tissue healing and regeneration.


The growth factors present in PRGF - ENDORET® help stimulate the biological processes involved in the repair and regeneration of soft and hard tissues.
The leukocyte-free formulation helps reduce the release of pro-inflammatory mediators associated with the surgical procedure, supporting a more controlled tissue response.
It supports appropriate organisation of the repaired tissue and contributes to soft tissue healing following dental surgical procedures.
Its application may help reduce inflammation and post-operative discomfort associated with certain surgical procedures.
Its versatility allows it to be combined with different bone and soft tissue regeneration techniques to improve the biological environment of the treated area.
Texto de ejemplo
Our quality system ensures product excellence throughout the entire life cycle, from design to disposal after the intended use has been fulfilled.
Our products are manufactured in accordance with ISO 13485 and MDSAP standards and comply with the requirements of European Medical Devices Directive 93/42/EEC and Regulation MDR 2017/745.

BTI al día
Rhoncus platea donec id est massa imperdiet cras. A dictumst aliquam at non magnis. Nec dolor sed vitae scelerisque enim id urna lorem diam. Quam duis turpis dolor pellentesque ac sed massa. Lectus magna turpis.
Saber másArtículos científicos
Statement of problem: The seal at the implant-abutment connection (IAC) is crucial for ensuring implant-prosthetic function and reducing the risk of peri-implant diseases.
BTI Channel
Statement of problem: The seal at the implant-abutment connection (IAC) is crucial for ensuring implant-prosthetic function and reducing the risk of peri-implant diseases.
BTI Publishing
Libro en el que se muestra el abordaje biológico para el tratamiento del alveolo postextracción, basado en el uso de factores de crecimiento plaquetarios.
Yes. As it is an autologous product obtained from the patient’s own blood, the risk of immunological reactions or disease transmission is minimised. It must be prepared in accordance with established protocols and using devices authorised for this purpose.
PRGF - ENDORET® may be used as an adjunct in oral implantology, oral surgery, periodontics, bone and soft tissue regeneration, alveolar preservation, maxillary sinus elevation, and other procedures in which the aim is to optimise healing and tissue regeneration.
Its use may help improve tissue healing, support the biological stability of the surgical environment, and optimise the regenerative processes associated with the placement of dental implants.
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
Texto de ejemplo
¡Gracias!